NCT05760157 is a clinical trial of Possible risk factors of heart failure in Heart Failure, sponsored by Jian Liu.

Who is sponsoring NCT05760157?

NCT05760157 is sponsored by Jian Liu.

What drugs are being tested in NCT05760157?

Interventions in NCT05760157: Possible risk factors of heart failure.

What condition does NCT05760157 study?

NCT05760157 studies Heart Failure, Acute Myocardial Infarction.

Is NCT05760157 still recruiting?

NCT05760157 is currently status unknown. Last updated 8 March 2023.

Last reviewed 2023-03-08 · How we verify

NCT05760157

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mulltimodal Dynamic Risk Assessment Systems of Heart Failure in Patients With Myocardial Infarction.

Status unknown Last updated 8 March 2023

What this trial tests

trial testing Possible risk factors of heart failure in Heart Failure in 567 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Jian Liu
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	567
Start date	1 January 2023
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across China

Drugs / interventions tested

Possible risk factors of heart failure

Conditions studied

Heart Failure — all drugs for Heart Failure →
Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Jian Liu

Who can join

Adults 18 to 75, any sex, with Heart Failure or Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore the heart failure risk model based on the dynamic data of patients with different outcome nodes after myocardial infarction to correct the heart failure risk of patients timely.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05760157 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jian Liu
Last refreshed: 8 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing